Related Experiment Video
Updated: Jan 22, 2026

Characterizing Mediated Extracellular Electron Transfer in Lactic Acid Bacteria with a Three-Electrode, Two-Chamber Bioelectrochemical System
Published on: August 23, 2024
17beta-estradiol acting as an electron mediator: experiments in vitro
Nikola Getoff1, Heike Schittl, Marion Gerschpacher
1Section of Radiation Biology, Faculty of Life Sciences, University of Vienna, A-1090 Vienna, Austria. nikola.getoff@univie.ac.at
This study reveals that 17beta-estradiol (17betaE2) and its complex with HBC exhibit anticancer properties when exposed to reducing free radicals, while acting as radioprotectors against oxidizing radicals in breast cancer research.
Area of Science:
- Biochemistry
- Free Radical Chemistry
- Cancer Research
Background:
- 17beta-estradiol (17betaE2) metabolism can produce carcinogenic metabolites.
- Investigating the role of free radicals in 17betaE2's effect on breast cancer initiation is crucial.
- Understanding the dual action of oxidizing and reducing radicals on 17betaE2 is key.
Purpose of the Study:
- To determine the effect of oxidizing and reducing free radicals on 17betaE2.
- To evaluate the potential of 17betaE2 and its derivatives in breast cancer initiation.
- To explore the radioprotective and anticancer properties of 17betaE2-based systems.
Main Methods:
- Exposure of 17betaE2 and 2-hydroxypropyl-beta-cyclodextrin (HBC) to gamma-ray induced free radicals.
- Utilizing aqueous media saturated with air, N(2)O, or argon.
- Employing Escherichia coli bacteria as a biological model system.
Main Results:
- 17betaE2 and HBC effectively scavenge hydroxyl (OH) and superoxide (O(2)(*-)) radicals.
- Intermediates formed by reducing radicals (e(-)(aq), H) show significant anticancer properties.
- DeltaD(37) values indicate radiation protection by oxidizing radicals and anticancer effects from reducing radicals.
Conclusions:
- The reactivity of free radicals dictates the outcome of their interaction with 17betaE2 and HBC.
- Oxidizing radicals confer radioprotection, evidenced by positive DeltaD(37) values.
- Reducing radicals demonstrate anticancer effects, indicated by negative DeltaD(37) values.
More Related Videos
06:12Study of Dendritic Cell Development by Short Hairpin RNA-Mediated Gene Knockdown in a Hematopoietic Stem and Progenitor Cell Line In vitro
Published on: March 7, 2022
08:44Measurements of Long-range Electronic Correlations During Femtosecond Diffraction Experiments Performed on Nanocrystals of Buckminsterfullerene
Published on: August 22, 2017
Related Concept Videos
Electron Carriers
Over the many stages of cellular respiration, glucose breaks down into carbon dioxide and water. Electron carriers pick up electrons lost by glucose in these reactions, temporarily storing and releasing them into the electron...
Forces Acting on Chromosomes
Microtubules and motor proteins exert two types of forces on...
The Stanford Prison Experiment
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Drugs Acting on Autonomic Ganglia: Blockers